WallStSmart

MasTec Inc (MTZ)vsStryker Corporation (SYK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Stryker Corporation generates 65% more annual revenue ($25.27B vs $15.28B). SYK leads profitability with a 13.2% profit margin vs 3.0%. SYK appears more attractively valued with a PEG of 1.40. MTZ earns a higher WallStSmart Score of 58/100 (C).

MTZ

Buy

58

out of 100

Grade: C

Growth: 9.3Profit: 5.5Value: 2.0Quality: 6.0
Piotroski: 4/9Altman Z: 2.59

SYK

Buy

57

out of 100

Grade: C

Growth: 6.0Profit: 7.0Value: 4.7Quality: 6.0
Piotroski: 3/9Altman Z: 2.18
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MTZSignificantly Overvalued (-38.8%)

Margin of Safety

-38.8%

Fair Value

$190.97

Current Price

$433.28

$242.31 premium

UndervaluedFair: $190.97Overvalued
SYKOvervalued (-11.3%)

Margin of Safety

-11.3%

Fair Value

$265.23

Current Price

$292.33

$27.10 premium

UndervaluedFair: $265.23Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MTZ2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
34.5%10/10

Revenue surging 34.5% year-over-year

EPS GrowthGrowth
508.0%10/10

Earnings expanding 508.0% YoY

SYK1 strengths · Avg: 9.0/10
Market CapQuality
$112.88B9/10

Large-cap with strong market position

Areas to Watch

MTZ4 concerns · Avg: 3.0/10
Price/BookValuation
10.4x4/10

Trading at 10.4x book value

Profit MarginProfitability
3.0%3/10

3.0% margin — thin

Operating MarginProfitability
3.7%3/10

Operating margin of 3.7%

PEG RatioValuation
2.542/10

Expensive relative to growth rate

SYK3 concerns · Avg: 3.7/10
P/E RatioValuation
35.1x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : MTZ

The strongest argument for MTZ centers on Revenue Growth, EPS Growth. Revenue growth of 34.5% demonstrates continued momentum.

Bull Case : SYK

The strongest argument for SYK centers on Market Cap. PEG of 1.40 suggests the stock is reasonably priced for its growth.

Bear Case : MTZ

The primary concerns for MTZ are Price/Book, Profit Margin, Operating Margin. A P/E of 82.7x leaves little room for execution misses. Thin 3.0% margins leave little buffer for downturns.

Bear Case : SYK

The primary concerns for SYK are P/E Ratio, Revenue Growth, Piotroski F-Score.

Key Dynamics to Monitor

MTZ profiles as a hypergrowth stock while SYK is a value play — different risk/reward profiles.

MTZ carries more volatility with a beta of 1.80 — expect wider price swings.

MTZ is growing revenue faster at 34.5% — sustainability is the question.

SYK generates stronger free cash flow (415M), providing more financial flexibility.

Bottom Line

MTZ scores higher overall (58/100 vs 57/100) and 34.5% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MasTec Inc

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

MasTec, Inc., an infrastructure construction company, provides engineering, construction, installation, maintenance, and upgrade services for communications, energy, utilities, and other infrastructure primarily in the United States and Canada. The company is headquartered in Coral Gables, Florida.

Visit Website →

Stryker Corporation

HEALTHCARE · MEDICAL DEVICES · USA

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.

Visit Website →

Want to dig deeper into these stocks?